Mozart Therapeutics


mozart therapeutics health logo

Vision

hange the treatment paradigm for patients with autoimmune and inflammatory diseases.

Approach

Mozart is focused on developing disease-modifying therapies for autoimmune and inflammatory diseases. They aim to reset and restore the balance of the immune system by leveraging a novel pathway to develop first-in-class CD8 Treg modulators to delay onset, reduce severity and potentially reverse the course of disease that allow patients to lead normal lives.

CEO:

Katie Fanning

Founders:

Mark M. Davis, PhD

K. Christopher Garcia, PhD

Calvin Kuo, MD, PhD

First investment:

April 2021